San Francisco sees significant declines in HIV and STI testing during 2020 pandemic

The recent government meeting in San Francisco highlighted significant declines in HIV and STI testing during the COVID-19 pandemic, raising concerns about the potential long-term impacts on public health. The meeting, which focused on epidemiological data, revealed that HIV testing at medical sites dropped by 18% in 2020 compared to 2019, with the lowest levels recorded during the shelter-in-place orders. Community HIV testing saw an even steeper decline of 44%.

Despite the overall decrease in HIV diagnoses—down 22% from 2019 to 2020—experts warned that reduced testing could lead to missed cases. The data indicated that while the number of new diagnoses fell, disparities persisted, particularly among marginalized groups. Latinx individuals now represent the highest number of new HIV diagnoses, and there was a notable increase in diagnoses among cisgender women.

The meeting also addressed the concerning rise in syphilis cases among women, which increased by 195% from 2017 to 2020. This trend raises alarms about potential congenital syphilis cases, with five reported in 2020, marking the highest number in 26 years. The decline in testing and the potential return to higher-risk behaviors as pandemic restrictions ease could exacerbate these issues.

Commissioners expressed concern over the widening disparities in health outcomes, particularly between housed and unhoused populations. The meeting underscored the need for targeted outreach and improved access to care, especially for women and marginalized communities. The public health officials emphasized ongoing efforts to enhance testing and care access, aiming to return to pre-pandemic levels and address the unique challenges faced by different demographics.

As the city moves forward, the focus will remain on monitoring new diagnoses and improving care outcomes, particularly for those experiencing homelessness and other vulnerable populations. The meeting concluded with a commitment to continue addressing these disparities and enhancing public health strategies in San Francisco.